Inactive Instrument

Fresh Start Private Management Inc Share Price Other OTC

Equities

US35804J1025

Healthcare Facilities & Services

End-of-day quote Other OTC
- USD - Intraday chart for Fresh Start Private Management Inc
Sales 2022 214K 16.45M Sales 2023 89.16K 6.86M Capitalization 6.75M 519M
Net income 2022 -4M -308M Net income 2023 -3M -231M EV / Sales 2022 42.5 x
Net Debt 2022 1.61M 124M Net Debt 2023 1.75M 134M EV / Sales 2023 95.3 x
P/E ratio 2022
-1.61 x
P/E ratio 2023
-1.73 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 43.61%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 56 30/09/12
Chairman 55 12/09/13
President 75 28/02/19
Members of the board TitleAgeSince
President 75 28/02/19
Director/Board Member 64 31/03/19
Director/Board Member 56 28/02/19
More insiders
BioCorRx Inc., through its subsidiaries, develops and provides addiction treatment solutions for the treatment of substance use and other related disorders. Its Beat Addiction Recovery is a substance use disorder recovery program that typically includes its Cognitive Behavioral Therapy (CBT) modules along with peer support via mobile app along with medication prescribed by an independent treating physician under their discretion. The UnCraveRx Weight Loss Program is also a medication-assisted weight loss program that includes access to concierge on-demand wellness specialists, nutritionists, fitness experts, and personal support from behavioral experts. The Company, through its subsidiary, BioCorRx Pharmaceuticals Inc., is engaged in the development of BICX104, a subcutaneous implantable naltrexone pellet for the treatment of both opioid and alcohol use disorders. It is also engaged in the establishment of alcoholism and opioid addiction rehabilitation and treatment centers.
More about the company